Christ Hospital Ohio Launches CRISPR Clinical Trial for High Cholesterol

Christ Hospital in Cincinnati, Ohio has launched a CRISPR gene-editing clinical trial targeting patients with high cholesterol, expanding the therapeutic application of CRISPR beyond genetic diseases. The trial marks a significant broadening of CRISPR's reach into common cardiometabolic conditions, potentially affecting millions of patients.